Conditions: Diabetic Foot Ulcer
Keywords: Diabetic Foot Ulcers Neuroischaemic
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 62
Healthy volunteers: no

Brief summary:
The primary objective of this 6 month open-label extension trial is to evaluate long-term safety and tolerability of dalteparin in treatment of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arterial occlusive disease (PAOD) and peripheral neuropathy.

Detailed description:

Arms:
arm 1: Active study treatment

Interventions: intervention 1: Fragmin
Intervention descriptions: intervention 1: Pre-filled syringes containing a single dose of 5000 IU Fragmin/ Dalteparin Sodium

Protocol document: